{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T17:30:32Z","timestamp":1763141432184,"version":"3.41.0"},"reference-count":7,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>A 68-year-old man with a history of prostate cancer post\u2013primary treatment presented with rising prostate-specific antigen levels and was referred for <jats:sup>18<\/jats:sup>F-fluciclovine PET\/MRI to localize recurrent disease. PET\/MRI revealed a solitary focus of uptake in a soft tissue nodule in the anterior mediastinum, which was resected and found to be a type B2 thymoma. <jats:sup>18<\/jats:sup>F-fluciclovine uptake is mediated by amino acid transporters, primarily alanine-serine-cysteine transporter 2 and <jats:sc>l<\/jats:sc>-type amino acid transporter 1, previously demonstrated to be expressed on thymic carcinomas. This case highlights the possibility of overexpression of amino acid transporters in thymomas as well, rarely described before.<\/jats:p>","DOI":"10.1097\/rlu.0000000000003305","type":"journal-article","created":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T21:26:15Z","timestamp":1601501175000},"page":"e168-e170","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["18F-Fluciclovine Uptake in Thymoma Demonstrated on PET\/MRI"],"prefix":"10.1097","volume":"46","author":[{"given":"Lucas","family":"Tsikitas","sequence":"first","affiliation":[{"name":"Department of Radiology, New York University Long Island School of Medicine, Mineola"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shawn","family":"Karls","sequence":"additional","affiliation":[{"name":"Nuclear Medicine, Department of Radiology, New York University Grossman School of Medicine, New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anca-Oana","family":"Kranz","sequence":"additional","affiliation":[{"name":"Department of Radiology, New York University Long Island School of Medicine, Mineola"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kent P.","family":"Friedman","sequence":"additional","affiliation":[{"name":"Nuclear Medicine, Department of Radiology, New York University Grossman School of Medicine, New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Mahajan","sequence":"additional","affiliation":[{"name":"Nuclear Medicine, Department of Radiology, New York University Grossman School of Medicine, New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,9,17]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2214\/AJR.19.21894","article-title":"Extraprostatic uptake of 18F-fluciclovine: differentiation of nonprostatic neoplasms from metastatic prostate cancer","volume":"214","year":"2020","journal-title":"AJR Am J Roentgenol"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s00259-012-2291-9","article-title":"Regional distribution and kinetics of [18F]fluciclovine (anti-[18F]FACBC), a tracer of amino acid transport, in subjects with primary prostate cancer","volume":"40","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"S260","DOI":"10.1097\/JTO.0b013e3181f1f62d","article-title":"Epidemiology of thymoma and associated malignancies","volume":"5","year":"2010","journal-title":"J Thorac Oncol"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1097\/JTO.0000000000000654","article-title":"The 2015 World Health Organization Classification of Tumors of the Thymus: continuity and changes","volume":"10","year":"2015","journal-title":"J Thorac Oncol"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"e2655","DOI":"10.1038\/cddis.2016.222","article-title":"Amino-acid transporters in T-cell activation and differentiation","volume":"8","year":"2017","journal-title":"Cell Death Dis"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/jso.21277","article-title":"l-Type amino acid transporter 1 (LAT1) is frequently expressed in thymic carcinomas but is absent in thymomas","volume":"99","year":"2009","journal-title":"J Surg Oncol"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.2967\/jnumed.114.143628","article-title":"Anti\u20131-amino-3-18F-fluorocyclobutane-1-carboxylic acid: physiologic uptake patterns, incidental findings, and variants that may simulate disease","volume":"55","year":"2014","journal-title":"J Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003305","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T21:03:58Z","timestamp":1750539838000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,17]]},"references-count":7,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000003305","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"type":"electronic","value":"1536-0229"},{"type":"print","value":"0363-9762"}],"subject":[],"published":{"date-parts":[[2020,9,17]]}}}